SIREN : 810279505
HEMISPHERES SANTE is a French company founded 11 years ago, specialized in the sector Formation continue d'adultes. Based in PARIS (75005), this company of category ETI shows in 2024 a revenue of 710 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 709 724 € | 752 150 € | 571 740 € | 693 591 € | 714 966 € | 1 080 519 € | 624 639 € |
| Net income | 10 589 € | 51 777 € | 90 079 € | 105 566 € | 74 462 € | 45 116 € | 16 844 € |
| EBITDA | 18 423 € | 79 901 € | 123 186 € | 153 420 € | 109 747 € | 54 238 € | 23 084 € |
| Net margin | 1.5% | 6.9% | 15.8% | 15.2% | 10.4% | 4.2% | 2.7% |
In 2024, HEMISPHERES SANTE achieves revenue of 710 k€. Revenue is growing positively over 7 years (CAGR: +1.8%). Slight decline of -6% vs 2023. After deducting consumption (0 €), gross margin stands at 710 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 18 k€, representing 2.6% of revenue. Warning negative scissor effect: despite revenue change (-6%), EBITDA varies by -77%, reducing margin by 8.0 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 11 k€, i.e. 1.5% of revenue. This profit can be retained or distributed to shareholders.
709 724 €
709 724 €
18 423 €
16 518 €
10 589 €
2.6%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 1.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
0.008%
61.059%
1.735%
0.003
In 2024, the debt ratio of HEMISPHERES SANTE (0.01) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of HEMISPHERES SANTE (61.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of HEMISPHERES SANTE (0.00) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 256.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 9.9x. Operating income very largely covers interest expenses: high safety margin.
256.003
9.906
In 2024, the liquidity ratio of HEMISPHERES SANTE (256.00) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of HEMISPHERES SANTE (9.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 194 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 80 days. The gap of 114 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 206 days of revenue, i.e. 406 k€ to permanently finance. Over 2017-2024, WCR increased by +141%, requiring additional financing.
405 614 €
194 j
80 j
0 j
206 j
Based on 134 transactions of similar company sales (all years), the value of HEMISPHERES SANTE is estimated at 102 296 € (range 34 949€ - 234 381€). With an EBITDA of 18 423€, the sector multiple of 2.2x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 134 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare HEMISPHERES SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Formation continue d'adultes
The revenue of HEMISPHERES SANTE in 2024 is 710 k€.
Yes, HEMISPHERES SANTE generated a net profit of 11 k€ in 2024.
The headquarters of HEMISPHERES SANTE is located in PARIS (75005), in the department Paris.
The tax return of HEMISPHERES SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
HEMISPHERES SANTE operates in the sector Formation continue d'adultes (NAF code 85.59A). See the 'Sector positioning' section above to compare the company with its competitors.